Assessment of Mean Fetal Kidney Length as a Reliable Parameter for Accurate Estimation of Gestational Age in Late 2nd and 3rd Trimesters
Fetal Kidney Length and Gestational Age in Late 2nd and 3rd Trimesters
1 other identifier
observational
100
1 country
1
Brief Summary
Accurate GA estimation is necessary when early termination of pregnancy is necessary as soon as the fetus becomes mature e.g. cases of pre-eclampsia, chronic renal disease, severe intrauterine growth retardation (IUGR), diabetes and placenta praevia centralis. Accurate GA estimation is also necessary where certain tests need to be performed for example amniotic fluid and serum assays, chorionic villus sampling and to plan fetal therapies. (Gupta DP et al., 2013)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2024
CompletedFirst Submitted
Initial submission to the registry
September 12, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedMarch 2, 2026
February 1, 2026
1.5 years
September 12, 2025
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of estimation of mean fetal kidney length in comparison with other parameters
Estimation of the gestational age (GA) in weeks by measurement of mean fetal kidney length (MFKL)in mm and detect its accuracy in correlation with gestational age derived from other traditional fetal parameters (BPD, HC, AC\& FL) in mm and actual gestational age derived from first day of last menstrual period.
18months
Eligibility Criteria
Healthy pregnant women at their late second and third trimester by reliable LMP who will meet the inclusion criteria, attend the fetal medicine Unit at Cairo University Hospital and consent to participate in this study.
You may qualify if:
- All healthy women with viable normal singleton pregnancies in their late second and third trimesters (24 weeks - 40 weeks) calculated from their last menstrual period.
- Women who will sure of the dates of their last menstrual period (1st day) and/or those with first obstetrics dating using crown rump length (CRL). 3- Women with regular menstrual cycle in last three months before their last menstrual period.
You may not qualify if:
- Women with high-risk pregnancies such as preeclampsia, diabetes, hypertension, polyhydramnios.
- ❖ Maternal:
- Multiple pregnancies.
- Gross maternal obesity.
- ❖ Fetal:
- Fetus with congenital anomalies especially renal anomalies.
- Fetuses with abnormal renal morphology (a genesis, hypoplasia, cysts, nephromegaly, polycystic kidney, hydronephrosis, etc.…
- Fetuses with renal pelvic dilatation of 5 mm or greater, obscured adrenal and renal border.
- Fetus with growth abnormalities (intrauterine growth retardation or macrosomia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Medicine, Cairo University
Giza, Cairo Governorate, 4240310, Egypt
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of Obstetrics and Gynecology faculty of medicine
Study Record Dates
First Submitted
September 12, 2025
First Posted
September 23, 2025
Study Start
July 21, 2024
Primary Completion
January 21, 2026
Study Completion
February 1, 2026
Last Updated
March 2, 2026
Record last verified: 2026-02